Cargando…
Structural Modification in Anesthetic Drug Development for Prodrugs and Soft Drugs
Among the advancements in drug structural modifications, the increased focus on drug metabolic and pharmacokinetic properties in the anesthetic drug design process has led to significant developments. Drug metabolism also plays a key role in optimizing the pharmacokinetics, pharmacodynamics, and saf...
Autores principales: | Deng, Chaoyi, Liu, Jin, Zhang, Wensheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283706/ https://www.ncbi.nlm.nih.gov/pubmed/35847008 http://dx.doi.org/10.3389/fphar.2022.923353 |
Ejemplares similares
-
Glutathione S-conjugates as prodrugs to target drug-resistant tumors
por: Ramsay, Emma E., et al.
Publicado: (2014) -
The Sodium Channel as a Target for Local Anesthetic Drugs
por: Fozzard, Harry A., et al.
Publicado: (2011) -
Anesthetic drug concentrations and placental transfer rate in fetus between term and preterm infants, twins, and singletons
por: Liu, Hao, et al.
Publicado: (2023) -
Chemotherapeutic drugs for soft tissue sarcomas: a review
por: Tian, Zhichao, et al.
Publicado: (2023) -
Drug development progress in duchenne muscular dystrophy
por: Deng, Jiexin, et al.
Publicado: (2022)